top of page
Search

The Beta Bionics iLet Bionic Pancreas: What It Actually Does (and Who Should Consider It)

  • Jul 2, 2024
  • 9 min read

Updated: 6 days ago

The "artificial pancreas" label gets thrown around a lot in diabetes tech, and honestly, it sets up expectations that no device can fully meet. I say this as someone who has spent 27 years navigating the gap between what diabetes gear promises and what it actually delivers at 2am when your CGM has decided to be dramatic.


(Visual/auditory learner? Watch the video instead!!)


What I can tell you: the Beta Bionics iLet Bionic Pancreas is one of the most genuinely low-burden AID systems on the market right now. Not because it's perfect. Because it made one specific trade-off on purpose, and whether that trade-off works for you depends entirely on your brain and your lifestyle.


Let me break it down.


Quick Take - FDA-cleared May 2023 for T1D aged 6+. - Now works with Dexcom G6, G7, AND FreeStyle Libre 3 Plus (updated October 2024). - Clinical evidence: 4 randomized controlled trials (n=1,130) showed HbA1c reduced by 0.5% and time in range improved ~11% vs standard care (Kumar et al., 2025). - Setup requires only your body weight. No carb ratios, no basal rates, no carb counting. Hard limitation: no manual mode when CGM fails. - Finger sticks every 4 hours if your sensor goes down.


What Is the Beta Bionics iLet Bionic Pancreas?

The iLet Bionic Pancreas is an FDA-cleared automated insulin delivery (AID) system for people with type 1 diabetes aged 6 and older, cleared May 19, 2023 (FDA, 2023). It pairs with your CGM (currently the Dexcom G6, Dexcom G7, or FreeStyle Libre 3 Plus, added October 2024) and makes 100% of your insulin dosing decisions autonomously. You enter your body weight in kilograms. That's the only input it ever needs. No preset basal rates, no insulin-to-carb ratios, no prior insulin history required.


Every five minutes, the iLet reads your CGM data and calculates a dose based on your glucose history from the past 24 hours, your current reading, and your insulin on board. It's doing the math constantly, in the background, without asking you to participate. For anyone whose brain runs on a different operating system from the one diabetes management was designed for, that's not a minor feature. That's the whole point.


The device itself has had a hardware update since launch: Beta Bionics released the Color iLet, featuring a color screen and brighter display. It also hit 10,000 commercial patient starts in August 2024, which gives us real-world data beyond the clinical trials.



How Does the iLet Handle Meal Dosing?

The iLet's meal dosing system is probably the feature that surprises people most. In a 2025 meta-analysis of 4 randomized controlled trials (n=1,130 people with T1D), the iLet produced a pooled HbA1c reduction of 0.5% and a time-in-range improvement of approximately 11% compared to standard care, and it did this using a three-option meal announcement system instead of carb counting (Kumar et al., Endocrinology, Diabetes & Metabolism, 2025, PMID: 41157817).


Here's how it works. When you're about to eat, you tell the pump one of three things:

  • Usual: your typical meal size

  • Less: roughly 50% less than usual

  • More: roughly 50% more than usual


That's it. No gram counting. No label squinting. The iLet estimates your carb intake from that single data point and doses accordingly, learning your patterns over time for breakfast, lunch, and dinner separately.


Unlike traditional insulin pumps, which require extensive user input for basal rates and insulin-to-carb ratios, the iLet simplifies the process. When you start using the pump, you only need to enter your body weight in kilograms. That’s it. The pump uses this single data point to set dynamic basal rates, which adjust autonomously. The basal rate is limited to 0.05 units per hour per kilogram of body mass.


For neurodivergent users specifically: this meal system is actually more forgiving than it sounds. Because it's estimating rather than calculating precisely, a "usual" announcement on a day when you ate more isn't catastrophic — the algorithm adjusts. The system is designed to course-correct, not to punish deviation. This is the opposite of how most AID systems handle meal dosing.

There is a catch: this design may not work as well for frequent small snacks throughout the day. The pump is calibrated around the rhythm of distinct meals. Grazers, take note.


What Does the Evidence Actually Show?

In the pivotal trial (the study that got the iLet its FDA clearance), adults using the iLet saw HbA1c drop from 7.9% to 7.3% over 13 weeks, while the standard care group stayed flat at 7.7% (adjusted difference: −0.5%, p<0.001). Time in range improved by roughly 2.6 hours per day more than standard care. The youth trial showed identical results: HbA1c dropped from 8.1% to 7.5% in the iLet group versus no change in standard care (Bionic Pancreas Research Group, New England Journal of Medicine, 2022).


A 2025 systematic review and meta-analysis pooled all four randomized controlled trials (n=1,130) and confirmed these results hold up: SMD −0.50 for HbA1c [95% CI: −0.63 to −0.38] and SMD 0.58 for TIR [95% CI: 0.43 to 0.73]. Severe hypoglycemia did not differ significantly between groups (Kumar et al., Endocrinology, Diabetes & Metabolism, 2025).

Real-world data backs this up too. Among the 10,000+ commercial users, baseline HbA1c values were higher than the trial participants, meaning more room to improve, and the reductions were correspondingly larger (Beta Bionics real-world data registry, 2025).


A 2025 randomized clinical trial also tested the iLet in primary care and telehealth settings (not specialist endocrinology clinics) and found glucose outcomes remained significantly better than usual care. This matters for access: you may not need to be at a major diabetes center to use it successfully (Clinical Diabetes, 2025).



Where the iLet Shines (Especially If Executive Function Is Already Taxed)


The iLet was cleared by the FDA in May 2023 as a genuinely novel system: no prior insulin history, no carb ratios, no basal programming required. You enter your weight in kilograms. The system does the rest. If your executive function is already running at a deficit by 9am, removing those setup variables entirely is not a small thing. Most AID systems reduce cognitive load compared to multiple daily injections. The iLet reduces it further than any other currently available option by eliminating the setup variables completely.


No carb counting. I know how much energy carb counting takes. The constant negotiation between "what did I actually eat" and "what did I think I was going to eat" is its own executive function task, happening at every single meal whether or not your working memory is cooperating that day. The iLet removes that entirely.


Pre-filled cartridges. For anyone with dexterity challenges or sensory issues around fine motor tasks, the pre-filled option removes one more high-stakes small-motor demand from the daily stack.


Now compatible with FreeStyle Libre 3 Plus. As of October 2024, the iLet works with the Abbott FreeStyle Libre 3 Plus in addition to the Dexcom G6 and G7. The original version of this post said Dexcom only. That's no longer accurate. If you're already on Libre 3 Plus, you now have a path to the iLet without switching CGMs.


Wireless charging. MagSafe-style charging: place it on the pad, walk away. No pins to align, no cable to find at 11pm.


Color iLet. The updated hardware has a color screen and brighter display. Small thing, but it matters for anyone who finds the original screen hard to read quickly.



Where the iLet Falls Short

Honesty first. Every pump has trade-offs, and the iLet's are specific enough to matter for certain users.


No manual mode. This is the one that stops some people cold. If your CGM sensor fails or expires, the pump can't fall back on a preset basal rate because there are no preset basal rates. The algorithm needs CGM data to function. Without it, you're doing finger sticks every four hours to keep the pump running. If a CGM failure mid-day is a scenario you think about a lot, factor this in.


Designed for structured meals, not all-day snacking. The "usual, less, more" system works best when you eat in distinct meals. If your eating pattern is more like continuous small amounts throughout the day (by preference, ARFID, or hyperfocus eating), this dosing model doesn't map cleanly onto your life.


CGM options, while expanded, are still limited. Dexcom G6, Dexcom G7, FreeStyle Libre 3 Plus. If you use the Libre 2, G5, or anything else, you can't use the iLet yet.


The battery is proprietary. The rechargeable battery is device-specific. Beta Bionics will send a second battery on request, which helps. But if you're someone who loses chargers (hello, ADHD) or travels frequently, build a backup charging setup into your kit from day one.



Who Should (and Shouldn't) Consider the iLet?

The iLet was cleared for T1D aged 6 and older. It is not FDA-cleared for type 2 diabetes. If you have T2D and are insulin-dependent, talk to your endocrinologist about other AID options that may fit better.


The iLet may be worth discussing with your care team if:

  • You want to reduce the daily decision load of diabetes as much as possible

  • Carb counting is a consistent pain point, whether because of ADHD, sensory issues with food, or fatigue

  • You're comfortable letting the algorithm lead and course-correct

  • You eat in generally distinct meals (not exclusively, but mostly)

  • You're willing to manage CGM uptime carefully given the no-manual-mode limitation


The iLet may not be the right fit if:

  • You prefer manual control and want to be able to override insulin delivery anytime

  • Your eating pattern is primarily grazing or frequent small amounts

  • You have very tight glucose targets for a specific medical reason (pregnancy, pre-transplant): discuss with your endocrinologist first

  • You're on a CGM not currently supported by the iLet


Worth noting on cost: the iLet is covered under most commercial insurance, Medicare, and Medicaid, with pharmacy benefit coverage under many plans as well. If cost is a barrier, Beta Bionics has a patient access program, and a CDCES or diabetes educator can help navigate the prior authorization process.



Frequently Asked Questions


Does the iLet bionic pancreas work for type 2 diabetes?

No. As of 2026, the iLet is FDA-cleared for type 1 diabetes in people aged 6 and older. It is not cleared for T2D. If you have insulin-dependent T2D, AID options like Omnipod 5 may be available, depending on your insurance and prescriber. Talk to your endocrinologist about which system fits your specific situation.


What happens if my CGM fails while using the iLet?

Without CGM data, the iLet can't calculate doses autonomously. You'll need to do finger sticks every four hours to keep the pump operating. This is the iLet's most significant limitation, and it's worth having a backup plan in place before you need it. Some users keep a backup CGM sensor ready to insert; others keep MDI supplies on hand for CGM downtime.


Do I have to count carbs to use the iLet?

No. That's the core design choice. You announce "usual," "less," or "more" before a meal, and the algorithm does the rest. Over time, it learns your individual patterns for breakfast, lunch, and dinner separately, which improves dosing accuracy. No gram counting required.


Is the iLet covered by insurance?

Most commercial plans, Medicare, and Medicaid cover the iLet and associated supplies. Pharmacy benefit coverage is also available under many plans. Prior authorization is usually required. If you run into barriers, your CDCES or diabetes care team can help with the PA process. That's specifically what they're there for.


What CGMs are compatible with the iLet?

As of October 2024: the Dexcom G6, Dexcom G7, and FreeStyle Libre 3 Plus. The original iLet launch was Dexcom-only; Libre 3 Plus integration was added in late 2024. No other CGMs are currently supported. Beta Bionics has not announced timelines for additional CGM compatibility.



The iLet is the lowest-setup AID system currently available, and the clinical evidence is solid. Whether it's right for your brain and your eating patterns is a different question, one worth spending some real time on before you switch, not after.


Questions? Drop them in the comments or find me on Instagram @givemesomesugardiabetes. And if you've been on the iLet, I genuinely want to know how it's going. The real-world picture is still filling in.


Love always,

Rachel


 TL;DR: The Beta Bionics iLet requires only your body weight at setup and automates 100% of insulin dosing decisions using CGM data. In 4 RCTs (n=1,130), it reduced HbA1c by 0.5% and time in range by ~11% vs standard care (Kumar et al., 2025). Now compatible with Dexcom G6, G7, AND FreeStyle Libre 3 Plus. Main trade-offs: no manual mode when CGM fails, not ideal for grazers. FDA-cleared for T1D aged 6+ only.


Sources

© 2026 Give Me Some Sugar. All rights reserved.

bottom of page